Bespoke Gene Therapy Consortium Coordination Center (BGTC CC) Electronic Data Capture (EDC) Platform Support
Awarded Limited / Sole Source Justification Posted
See the award notice from .
- Solicitation number
- HHSN316201500008W75N95025F00001
- Agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- HHSN316201500008W-75N95025F00001 Federal contract award
- Awardee
- Iqvia Government Solutions Inc.
- NAICS code
- 334111 Electronic Computer Manufacturing
- PSC
- 7H20 It And Telecom - Platform Products: Database, Mainframe, Middleware (Hw, Perpetual License Software)
- Place of performance
- Falls Church, Virginia 22042, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse has issued a Limited / Sole Source Justification Notice for the Bespoke Gene Therapy Consortium Coordination Center (BGTC CC) Electronic Data Capture (EDC) Platform Support. The objective is to obtain cloud platform services to support data collection, dissemination, analysis, integration, reporting, and management of the BGTC, which is part of the Accelerating Medicines Partnership program. The National Center for Advancing Translational Sciences has determined that IQVIA Government Solutions, Inc., the incumbent subcontractor, is the only vendor capable of performing this requirement. The acquisition will be a firm-fixed-price contract with options, with a total estimated value of up to from 11/1/2024 to 10/31/2029. NCATS will maintain control of the data environment and platform to ensure privacy, security, and long-term sustainability.
Notice text
The objective of this acquisition is to obtain cloud platform services to support data collection, dissemination, analysis, integration, reporting, and management of the BGTC.
The BGTC is part of the Accelerating Medicines Partnership (AMP) program, a public–private partnership among NIH, the U.S. Food and Drug Administration (FDA), multiple pharmaceutical and life sciences companies, and nonprofit and other organizations. The AMP program, which is managed by the Foundation for the NIH (FNIH), aims to improve current models for developing diagnostics and therapies. NCATS is the lead NIH IC for BGTC, one of several NCATS-led programs aligned with the NCATS’ mission to re-engineer the translational research process so new treatments and cures for diseases can be delivered to patients faster. The BGTC is establishing platforms and standards to speed the development and delivery of customized or “bespoke” gene therapies (GT) that could treat millions of people affected by rare diseases, including diseases too rare to be of commercial interest.
Awarded contract HHSN316201500008W to unknown vendor for unknown amount on 2024-11-21.
Files
| File | Type | Posted |
|---|---|---|
| D JEFO Redacted.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| Bespoke Gene Therapy Consortium Coordination Center (BGTC CC) Electronic Data Capture (EDC) Platform Support | Award Notice | |
| This notice | Limited / Sole Source Justification |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Clinical Research Support and Collaboration for NHGRI Protocols | Office of Logisitics and Acquisition Operations | Total Small Business |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity